Radiopharm Theranostics Revenue

In the fiscal year ending June 30, 2024, Radiopharm Theranostics had annual revenue of 1.96M AUD, down -68.46%. Radiopharm Theranostics had revenue of -2.11M in the half year ending June 30, 2024, with 8,777,958.33% growth.

Revenue (ttm)

1.96M AUD

Revenue Growth

-68.46%

P/S Ratio

27.33

Revenue / Employee

n/a

Employees

n/a

Market Cap

35.71M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	1.96M	-4.25M	-68.46%
Jun 30, 2023	6.21M	-	-
Jun 30, 2022	-	-	-
Jun 30, 2021	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition